Amaze Holdings enters the week of May 11 in a state of acute short-side pressure — short interest has exploded from near-zero to nearly a fifth of the free float in just ten days, while the borrow market has tightened to its most constrained level in recent memory.
The scale of the short build is remarkable. SI % FF closed at 18.2% on May 12, up from just 3.2% on May 5 and a negligible 0.07% on April 6. In raw share terms, estimated short positions rose more than 600% over the week. That's not a gradual lean — it's a concentrated surge, with the bulk of the build arriving between May 5 and May 8 when positions almost trebled in three sessions.
The borrow market has responded accordingly, and the signal is unambiguous: availability has collapsed. It now stands at 14.3% — meaning only one share remains available to borrow for every seven already lent out — down from over 140% as recently as April 30. That's not a tight market; it's nearly exhausted. Cost to borrow has risen alongside it, running at 14.2% APR. Notably, it spiked sharply to 42% on May 11 before pulling back — a sign the lending desk scrambled to reprice as demand surged. The ORTEX short score of 77.8 places AMZE in the top tier of short pressure across the universe, and the utilization rank sits in the 5th percentile globally, confirming how little headroom remains in the lending pool.
The price has fought back regardless. The stock gained 11% on May 12 alone and is up 16% on the week, now trading at $0.1531. That bounce against a backdrop of explosive short-building is the core tension: a $6.9 million market cap micro-cap facing a large and rapidly-assembled short position, with borrowable shares nearly exhausted. For context, earnings history has been brutal — three of the last four prints produced next-day declines averaging around 19%, with the most severe being a 29% drop on April 1. The next earnings event is scheduled for June 12.
The analyst picture offers little to anchor against. Ladenburg Thalmann initiated coverage in January with a Buy and a $3.00 target. At the current price of $0.15 that target is twenty times the market — likely reflecting either stale research or a company story that has deteriorated sharply since initiation. That data is too dated to carry weight here. The sole reliable valuation anchor is the enterprise value of approximately $8.2 million, which frames just how small this situation is. The EPS surprise factor score ranks in the 99th percentile, suggesting the company has historically beaten low expectations — though in a name this small, that figure warrants caution.
The setup heading into June 12 earnings is therefore defined by two competing forces: a short base that has grown explosively fast into near-zero borrow availability, and a stock that is already bouncing against those shorts. What to watch is whether availability tightens further toward zero — if it does, the cost of maintaining those positions rises sharply — and whether any catalyst ahead of the earnings date changes the supply/demand balance in the lending market.
See the live data behind this article on ORTEX.
Open AMZE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
